MedTrace Logo

Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements

NCT00783042 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2009-06-30

No results posted yet for this study

Summary

The aim of this study is to investigate whether the non-invasive ultrasound method for assessment of coronary blood flow, transthoracic Doppler echocardiography-coronary flow reserve (TTDE-CFR), can be used to measure drug effects.

Conditions

Interventions

DRUG

Rosuvastatin

40 mg, tablet, oral, once daily for 1 (double blind) +2 months (open).

DRUG

Placebo

Tablet, oral, once daily for 1 month (double blind)

Sponsors & Collaborators

Principal Investigators

  • Björn Fagerberg, MD, Professor · Wallenberg LaboratorySahlgrenska University Hospital, S-413 45 Göteborg

  • Maria Leonsson-Zachrissson, MD · AstraZeneca R&D Mölndal

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Completion
2009-05-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00783042 on ClinicalTrials.gov